035080.KQ
Gradiant Corporation
KOSDAQKRWEQUITY
DELAYED
Last price
11,880.00
▼ 120.00 (1.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
12,000.00
Day high
—
Day low
—
Volume
—
Market cap
—
P/E (TTM)
—
52W range
— – 15,300.00
Trailing performance
Returnvs SPY
1W
+0.51%
+1.9%
1M
+30.55%
+26.8%
3M
+19.64%
+16.5%
6M
+2.15%
-8.9%
YTD
+4.12%
-8.2%
1Y
-22.40%
-42.4%
3Y
-29.20%
-103.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on 035080.KQ open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $3.06T | $3.32T | $3.42T | $3.58T | -7.7% |
| Operating revenue | $3.06T | $3.32T | $3.42T | $3.58T | -7.7% |
| Cost of revenue | $2.90T | $3.16T | $3.27T | $3.43T | -8.3% |
| Gross profit | $161.69B | $156.62B | $154.29B | $155.14B | +3.2% |
| Research & development | $11.79B | $11.45B | $14.04B | $9.06B | +3.0% |
| Selling, general & admin | $37.25B | $36.59B | $32.12B | -$7.93B | +1.8% |
| Total operating expense | $191.16B | $162.13B | $151.36B | $140.44B | +17.9% |
| Operating income | -$29.47B | -$5.51B | $2.93B | $14.70B | -434.4% |
| Net interest income | $5.05B | $8.37B | $9.55B | $1.51B | -39.6% |
| Pre-tax income | -$22.67B | -$5.17B | -$6.55B | $1.68B | -338.5% |
| Tax provision | $2.04B | $20.79B | -$521.90M | -$856.87M | -90.2% |
| Net income | -$35.79B | -$40.38B | -$15.84B | $326.73B | +11.4% |
| Net income to common | -$35.79B | -$40.38B | -$15.84B | $326.73B | +11.4% |
| Basic EPS | -2,961.00 | -2,963.00 | -1,123.00 | 21,470.00 | +0.1% |
| Diluted EPS | -2,961.00 | -2,963.00 | -1,123.00 | 21,470.00 | +0.1% |
| EBIT | -$18.76B | -$1.99B | -$2.99B | $4.41B | -841.6% |
| EBITDA | $28.89B | $44.10B | $41.15B | $46.40B | -34.5% |
| Basic shares | 12.09M | 13.63M | 14.11M | 15.22M | -11.3% |
| Diluted shares | 12.09M | 13.63M | 14.11M | 15.22M | -11.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $181.35B | $221.32B | $251.96B | $193.90B | -18.1% |
| Cash & short-term investments | $314.79B | $362.30B | $393.97B | $433.09B | -13.1% |
| Accounts receivable | $633.71B | $607.87B | $650.27B | $601.06B | +4.2% |
| Inventory | $71.53B | $60.49B | $81.93B | $71.58B | +18.2% |
| Total current assets | $1.05T | $1.07T | $1.17T | $1.14T | -1.6% |
| Property, plant & equipment | $205.47B | $164.65B | $147.70B | $72.97B | +24.8% |
| Goodwill & intangibles | $163.54B | $190.36B | $214.37B | $240.39B | -14.1% |
| Total assets | $1.75T | $1.74T | $1.90T | $1.77T | +0.5% |
| Total current liabilities | $890.02B | $852.15B | $928.12B | $763.63B | +4.4% |
| Current debt | $123.89B | $146.15B | $102.37B | $31.97B | -15.2% |
| Long-term debt | $18.19B | $29.12M | $22.07B | $150.00M | +62,356.0% |
| Total debt | $198.80B | $180.09B | $164.56B | $75.55B | +10.4% |
| Total liabilities | $1.02T | $955.91B | $1.06T | $887.16B | +7.1% |
| Retained earnings | $273.65B | $309.24B | $365.94B | $405.59B | -11.5% |
| Shareholder equity | $442.47B | $498.19B | $550.34B | $589.41B | -11.2% |
| Working capital | $161.58B | $216.40B | $245.19B | $380.52B | -25.3% |
| Net tangible assets | $278.93B | $307.82B | $335.97B | $349.02B | -9.4% |
| Shares issued | 11.30M | 13.68M | 14.53M | 15.53M | -17.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$24.71B | -$25.96B | -$6.02B | $338.86B | +4.8% |
| Depreciation & amortisation | $47.65B | $46.09B | $44.15B | $41.99B | +3.4% |
| Stock-based compensation | $712.25M | $1.02B | $1.27B | $1.04B | -29.9% |
| Change in working capital | -$11.11B | -$74.08B | $27.17B | $38.85B | +85.0% |
| Operating cash flow | $12.87B | -$30.35B | $72.66B | $19.83B | +142.4% |
| Capital expenditure | -$23.31B | -$15.63B | -$79.02B | -$31.47B | -49.1% |
| Investing cash flow | $8.64B | $39.49B | -$51.29B | $135.61B | -78.1% |
| Share buybacks | -$19.99B | -$12.11B | -$15.48B | -$15.54B | -65.0% |
| Dividends paid | -$20.12B | -$22.44B | -$21.46B | -$22.41B | +10.3% |
| Financing cash flow | -$61.28B | -$41.54B | $36.74B | -$51.72B | -47.5% |
| Free cash flow | -$10.44B | -$45.98B | -$6.36B | -$11.64B | +77.3% |
| End cash position | $181.35B | $221.32B | $251.96B | $193.90B | -18.1% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $843.28B | $811.25B | $764.96B | $736.45B | $748.94B | +3.9% |
| Operating revenue | $843.28B | $811.25B | $764.96B | $736.45B | $748.94B | +3.9% |
| Cost of revenue | $799.32B | $766.20B | $725.31B | $699.04B | $709.36B | +4.3% |
| Gross profit | $43.96B | $45.05B | $39.65B | $37.41B | $39.58B | -2.4% |
| Research & development | $1.98B | $2.68B | $3.81B | $2.76B | $2.54B | -26.2% |
| Selling, general & admin | $7.75B | $8.92B | $9.10B | $10.14B | $9.10B | -13.1% |
| Total operating expense | $38.10B | $58.81B | $45.75B | $44.70B | $41.89B | -35.2% |
| Operating income | $5.87B | -$13.77B | -$6.10B | -$7.29B | -$2.31B | +142.6% |
| Net interest income | $1.27B | $1.47B | $1.02B | $947.49M | $1.62B | -13.4% |
| Pre-tax income | $8.54B | -$20.80B | -$4.87B | $8.27B | -$5.26B | +141.0% |
| Tax provision | $3.67B | -$5.30B | $479.35M | $4.98B | $1.88B | +169.3% |
| Net income | -$1.09B | -$17.20B | -$5.80B | -$4.42B | -$8.37B | +93.6% |
| Net income to common | -$1.09B | -$17.20B | -$5.80B | -$4.42B | -$8.37B | +93.6% |
| Basic EPS | -96.00 | — | -490.00 | -359.00 | -655.00 | — |
| Diluted EPS | -96.00 | — | -490.00 | -359.00 | -655.00 | — |
| EBIT | $9.61B | -$19.93B | -$3.95B | $9.23B | -$4.10B | +148.2% |
| EBITDA | $20.83B | -$8.32B | $7.63B | $21.66B | $7.92B | +350.4% |
| Basic shares | 11.41M | — | 11.83M | 12.31M | 12.78M | — |
| Diluted shares | 11.41M | — | 11.83M | 12.31M | 12.78M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $168.02B | $181.35B | $181.58B | $181.72B | $187.33B | -7.4% |
| Cash & short-term investments | $242.81B | $314.79B | $297.03B | $295.38B | $341.46B | -22.9% |
| Accounts receivable | $663.55B | $633.71B | $594.46B | $565.15B | $597.07B | +4.7% |
| Inventory | $83.41B | $71.53B | $83.40B | $76.73B | $69.87B | +16.6% |
| Total current assets | $1.03T | $1.05T | $1.01T | $974.71B | $1.04T | -2.3% |
| Property, plant & equipment | $234.39B | $205.47B | $199.06B | $193.39B | $197.51B | +14.1% |
| Goodwill & intangibles | $156.94B | $163.54B | $174.88B | $181.38B | $184.28B | -4.0% |
| Total assets | $1.80T | $1.75T | $1.70T | $1.68T | $1.76T | +3.1% |
| Total current liabilities | $958.67B | $890.02B | $814.14B | $774.05B | $866.48B | +7.7% |
| Current debt | $142.03B | $123.89B | $107.94B | $100.35B | $145.66B | +14.6% |
| Long-term debt | $18.32B | $18.19B | $18.05B | $17.92B | $16.64M | +0.7% |
| Total debt | $214.25B | $198.80B | $184.94B | $179.64B | $208.87B | +7.8% |
| Total liabilities | $1.09T | $1.02T | $955.36B | $922.98B | $998.36B | +6.3% |
| Retained earnings | $253.89B | $273.65B | $291.89B | $298.22B | $301.02B | -7.2% |
| Shareholder equity | $440.92B | $442.47B | $462.41B | $475.42B | $486.79B | -0.4% |
| Working capital | $68.26B | $161.58B | $194.00B | $200.65B | $176.91B | -57.8% |
| Net tangible assets | $283.98B | $278.93B | $287.53B | $294.05B | $302.50B | +1.8% |
| Shares issued | 11.43M | 11.30M | 13.68M | 13.68M | 13.68M | +1.2% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $4.86B | -$15.50B | -$5.35B | $3.28B | -$7.14B | — | +131.4% |
| Depreciation & amortisation | $11.22B | $11.62B | $11.58B | $12.43B | $12.02B | — | -3.4% |
| Stock-based compensation | $12.53M | $41.35M | $129.63M | $254.48M | $286.79M | — | -69.7% |
| Change in working capital | -$7.34B | -$2.47B | -$5.42B | -$10.66B | $7.45B | — | -197.1% |
| Operating cash flow | $3.02B | $10.14B | $2.71B | -$10.79B | $10.81B | — | -70.2% |
| Capital expenditure | -$20.12B | -$4.86B | -$7.34B | -$5.07B | -$6.03B | — | -313.8% |
| Investing cash flow | -$24.22B | -$13.37B | $5.02B | $54.64B | -$37.65B | — | -81.2% |
| Share buybacks | -$1.62B | -$2.20B | -$7.49B | -$7.21B | -$3.09B | — | +26.6% |
| Dividends paid | — | -$1.71B | -$1.71B | — | — | -$2.56B | — |
| Financing cash flow | $6.94B | $2.53B | -$8.28B | -$48.37B | -$7.16B | — | +174.4% |
| Free cash flow | -$17.10B | $5.27B | -$4.62B | -$15.87B | $4.78B | — | -424.1% |
| End cash position | $168.02B | $181.35B | $181.58B | $181.72B | $187.33B | — | -7.4% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
11,504.00
+3.27% from price
SMA 20
10,379.00
+14.46% from price
SMA 50
9,480.20
+25.31% from price
SMA 100
10,186.10
+16.63% from price
SMA 200
10,947.30
+8.52% from price
EMA 12
11,252.93
+5.57% from price
EMA 26
10,502.08
+13.12% from price
EMA 50
10,100.26
+17.62% from price
RSI (14)
73.4
Overbought
MACD (12,26,9)
750.85
Hist 169.76
ATR (14)
510.71
4.30% of price
Realised vol 30D
45.7%
Annualised
Bollinger upper
12,843.35
20, 2σ
Bollinger lower
7,914.65
20, 2σ
50 / 200 cross
Death
9,480.20 vs 10,947.30
Trend bias
Above 200
+8.52%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.03
Less volatile than market
Correlation to SPY
0.01
Largely independent
Realised vol 30D
45.7%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-50.5%
Peak to trough
Max drawdown 5Y
-84.9%
Peak to trough
ATR 14
510.71
4.30% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery?
Insider Monkey · 14m ago
Dow Jones Futures Fall With Tariffs In Focus; Nvidia, Warsh Ahead
Investor's Business Daily · 17m ago
Syria says Israel talks addressed de-escalation, staying out of Israel-Turkey tensions
AFP · 20m ago
FIA Hails Success of Landmark INDYCAR Freedom 250 Grand Prix as Motorsport Takes Centre Stage in Washington D.C.
Business Wire · 24m ago
The next big oil trade may have nothing to do with oil stocks
TheStreet · 24m ago
First lady Melania Trump says she 'loved' racing as a child
USA TODAY · 25m ago
Johnson & Johnson vs. Thermo Fisher: Which Healthcare Growth Story Is More Durable?
Insider Monkey · 25m ago
Crowder College offering training courses in August, September
The Joplin Globe, Mo. · 26m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.